Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Ni Raghallaigh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Translational Andrology and Urology|March 30, 2018
Men with a susceptibility to prostate cancer and the role of genetic based screeningRosalind Eeles, Holly Ni Raghallaigh
Familial Cancer|January 24, 2021
Genetic predisposition to prostate cancer: an updateHolly Ni Raghallaigh, Rosalind Eeles
BMJ Case Reports|November 5, 2014
'No bladder visible on ultrasound scan--has the patient had a cystectomy?' A case of emphysematous cystitisHolly Ni Raghallaigh, Sophie Rintoul-Hoad, Elizabeth Emsley, et al.
Current Genetic Medicine Reports|November 18, 2021
Updates in Prostate Cancer Research and Screening in Men at Genetically Higher RiskElizabeth K Bancroft, Holly Ni Raghallaigh, Elizabeth C Page, et al.
European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
The Lancet. Oncology|October 22, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.
European Urology|September 21, 2019
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth C Page, Elizabeth K Bancroft, Mark N Brook, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Translational Andrology and Urology|March 30, 2018
Men with a susceptibility to prostate cancer and the role of genetic based screeningRosalind Eeles, Holly Ni Raghallaigh
Familial Cancer|January 24, 2021
Genetic predisposition to prostate cancer: an updateHolly Ni Raghallaigh, Rosalind Eeles
BMJ Case Reports|November 5, 2014
'No bladder visible on ultrasound scan--has the patient had a cystectomy?' A case of emphysematous cystitisHolly Ni Raghallaigh, Sophie Rintoul-Hoad, Elizabeth Emsley, et al.
Current Genetic Medicine Reports|November 18, 2021
Updates in Prostate Cancer Research and Screening in Men at Genetically Higher RiskElizabeth K Bancroft, Holly Ni Raghallaigh, Elizabeth C Page, et al.
European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
The Lancet. Oncology|October 22, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.
European Urology|September 21, 2019
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth C Page, Elizabeth K Bancroft, Mark N Brook, et al.
Pageof 1